136 related articles for article (PubMed ID: 3742454)
1. Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification.
Christensson B; Tribukait B; Linder IL; Ullman B; Biberfeld P
Cancer; 1986 Sep; 58(6):1295-304. PubMed ID: 3742454
[TBL] [Abstract][Full Text] [Related]
2. Biological heterogeneity of diffuse mixed small and large cell non-Hodgkin's lymphomas assessed by DNA flow cytometry and Ki67.
Palestro G; Pich A; Chiusa L; Geuna M; Ponti R; Kerim S; Novero D; Valente G
Leuk Lymphoma; 1995 Nov; 19(5-6):467-72. PubMed ID: 8590848
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma.
Christensson B; Lindemalm C; Johansson B; Mellstedt H; Tribukait B; Biberfeld P
Leuk Res; 1989; 13(4):307-14. PubMed ID: 2716347
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia.
Diamond LW; Nathwani BN; Rappaport H
Cancer; 1982 Sep; 50(6):1122-35. PubMed ID: 7104953
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy, proliferative activities, and immunophenotype of malignant lymphoma: application of flow cytometry.
Horii A; Yoshida J; Hattori K; Honjo Y; Mitani K; Takashima S; Sakai M; Okamoto S; Kubo T
Head Neck; 1998 Aug; 20(5):392-8. PubMed ID: 9663666
[TBL] [Abstract][Full Text] [Related]
6. Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas.
Macartney JC; Camplejohn RS; Alder J; Stone MG; Powell G
J Clin Pathol; 1986 May; 39(5):542-6. PubMed ID: 3722408
[TBL] [Abstract][Full Text] [Related]
7. Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.
Joensuu H; Klemi PJ; Jalkanen S
Cancer; 1990 Jun; 65(11):2564-71. PubMed ID: 2337874
[TBL] [Abstract][Full Text] [Related]
8. Comparison of S-phase fraction, working formulation, and Kiel classification in non-Hodgkin's lymphoma.
Joensuu H; Klemi PJ; Söderström KO; Jalkanen S
Cancer; 1991 Oct; 68(7):1564-71. PubMed ID: 1893358
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.
Wu HM
J Tongji Med Univ; 1992; 12(2):65-70. PubMed ID: 1433420
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA-analysis by flow cytometry in non-Hodgkin's lymphoma.
Roos G; Dige U; Lenner P; Lindh J; Johansson H
Hematol Oncol; 1985; 3(4):233-42. PubMed ID: 4085977
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency.
McDunn SH; Winter JN; Variakojis D; Rademaker AW; Von Roenn JH; Tallman MS; Gordon LI; Bauer KD
J Clin Oncol; 1991 Aug; 9(8):1334-40. PubMed ID: 1677032
[TBL] [Abstract][Full Text] [Related]
12. Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
Coad NA; Jones TJ; Muir KR; Parkes SE; Smith K; Raafat F; Mann JR
Pediatr Pathol Lab Med; 1997; 17(6):893-902. PubMed ID: 9353829
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
14. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate intrapatient variation depending on circadian stage of cell sampling.
Smaaland R; Lote K; Sothern RB; Laerum OD
Cancer Res; 1993 Jul; 53(13):3129-38. PubMed ID: 8319221
[TBL] [Abstract][Full Text] [Related]
15. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
[TBL] [Abstract][Full Text] [Related]
16. Relation between enzymatic activities and the degree of malignancy of human lymphomas.
Vezzoni P; Giardini R; Raineri M; Pozzi MR; Lucchini R; Vezzoni MA; Clerici L; Besana C; Rugarli C; Rilke F
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):945-50. PubMed ID: 4043177
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
[TBL] [Abstract][Full Text] [Related]
18. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of low grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis.
Lackowska B; Wasilewska A; Gruchała A; Ryś J; Szklarski W; Niezabitowski A
Pol J Pathol; 1994; 45(4):263-9. PubMed ID: 7697327
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
